Goffredo, Donato <br/><br/>
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease.  [electronic resource] 

 -  Pharmacological research  Aug 2005 
 - 140-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1043-6618 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2005.01.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis Regulatory Proteins<br/>Brain--metabolism<br/>Carrier Proteins--metabolism<br/>Cell Line<br/>Cell Survival<br/>Cyclosporine--pharmacology<br/>Cytosol--metabolism<br/>High-Temperature Requirement A Serine Peptidase 2<br/>Humans<br/>Huntingtin Protein<br/>Huntington Disease--genetics<br/>Inhibitor of Apoptosis Proteins<br/>Intracellular Signaling Peptides and Proteins<br/>Mice<br/>Mitochondria--metabolism<br/>Mitochondrial Proteins--metabolism<br/>Mutation<br/>Nerve Tissue Proteins--genetics<br/>Nuclear Proteins--genetics<br/>Proteins--metabolism<br/>Pyrimidinones--pharmacology<br/>Serine Endopeptidases--metabolism<br/>Thiones--pharmacology<br/>Ubiquitin-Protein Ligases<br/>X-Linked Inhibitor of Apoptosis Protein